CoChat

Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines

Razzini, Giorgia, Berrie, Christopher P., Vignati, Sara, Broggini, Massimo, Mascetta, Giuseppe, Brancaccio, Anna, Falasca, Marco · 2000 · The FASEB Journal
Cited by 74

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

New efforts in cancer therapy are being focused at various levels of signaling pathways. With phosphoinositide 3‐kinase (PI3‐K) potentially being necessary for a range of cancer‐related functions, we have investigated the influence of selected inositol tristo hexakisphosphates on cell growth and tumorigenicity. We show that micromolar concentrations of inositol 1,3,4,5,6‐pentakisphosphate and inositol 1,4,5,6‐tetra‐kisphosphate [Ins(1,4,5,6)P 4 ] inhibit IGF‐1‐induced [ 3 H]‐thymidine incorporation in human breast cancer (MCF‐7) cells and the ability to grow in liquid medium and form colonies in agarose semisolid medium by small cell lung cancer (SCLC) cells, a human cancer cell line containing a constitutively active PI3‐K. In an ovarian cancer cell line that also contains a constitutively active PI3‐K (SKOV‐3 cells), Ins(1,4,5,6)P 4 again inhibited liquid medium growth. Furthermore, when applied extracellularly, inositol 1,3,4,5‐tetrakisphosphate was shown indeed to enter SCLC cells. These effects appeared specifically related to PH domains known to bind to phosphatidylinositol 3,4‐bisphosphate [PtdIns(3,4)P 2 ] and phosphatidylinositol 3,4,5‐trisphosphate [PtdIns(3,4,5)P 3 ], indicating involvement of the PI3‐K downstream target protein kinase B (PKB/Akt). This was further supported by inhibition of PKB/Akt PH domain membrane targeting in COS‐7 cells by Ins(1,4,5,6)P 4 . Thus, we propose that specific inositol polyphosphates inhibit PI3‐K by competing with PtdIns(3,4,5)P 3 ‐binding PH domains and that this occurs mainly at the level of the downstream PI3‐K target, PKB/Akt.—Razzini, G., Berrie, C. P., Vignati, S., Broggini, M., Mascetta, G., Brancaccio, A., Falasca, M. Novel functional PI 3‐kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. FASEB J. 14, 1179–1187 (2000)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fasebj.14.9.1179

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 74

Metadata

Authors
Razzini, G., Berrie, C. P., Vignati, S., Broggini, M., Mascetta, G., Brancaccio, A., & Falasca, M.
Venue
The FASEB Journal
Publisher
Wiley
Published
2000-06
Volume
14
Issue
9
Pages
1179-1187
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W1779463793
Cited by
74
References
2
FWCI
2.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.